STRATA Skin Sciences, Inc. Stock News

Medical device veteran poised to lead STRATA to market leadership and continued revenue growth as Company continues next development phase Medical device veteran poised to lead STRATA to market leadership and continued revenue growth as Company continues next development phase

Multicenter prospective RCT published in JAAD confirms superiority of XTRAC® Excimer Laser plus oral JAK inhibitors over tacrolimus combination therapy in children aged 2–18 years with progressive vitiligo, fueling continued market growth and expanding indications Multicenter prospective RCT published in JAAD confirms superiority of XTRAC® Excimer Laser plus oral JAK inhibitors over tacrolimus ...